Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2B, Prospective, Double-Blind, Randomized Controlled Trial of the Micronized DHACM Injectable Product Compared to Saline Placebo Injection for the Treatment of Osteoarthritis of the Knee

NCT05796765 is registered in ClinicalTrials.gov with MiMedx Group, Inc. as lead sponsor.

NCT NCT05796765
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05796765 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2B, Prospective, Double-Blind, Randomized Controlled Trial of the Micronized DHACM Injectable Product Compared to Saline Placebo Injection for the Treatment of Osteoarthritis of the Knee
Lead sponsor
MiMedx Group, Inc.
Phase
Phase 2
Overall status
Terminated
Start date
March 24, 2023
Completion date
December 15, 2023
Enrollment
43 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

knee osteoarthritis